April 2014 - 1 Hepatitis C Overview .

35
April 2014 - 1 Hepatitis C Overview www.hcvadvocate.org

Transcript of April 2014 - 1 Hepatitis C Overview .

Page 1: April 2014 - 1 Hepatitis C Overview .

April 2014 - 1

Hepatitis C Overview

www.hcvadvocate.org

Page 2: April 2014 - 1 Hepatitis C Overview .

2

Introduction

Advocacy & Self-Advocacy through Education

The information in this presentation is designed to help you understand and manage HCV and is not intended as medical advice. HCV medical care is a partnership between patients and their medical providers

www.hcvadvocate.org

Page 3: April 2014 - 1 Hepatitis C Overview .

3

The Liver – A Chemical Factory

Largest internal organ Size of a football Approximately 3 lbs in the average

sized male 1.5 quarts of blood flow through it

every minute

www.hcvadvocate.org

Page 4: April 2014 - 1 Hepatitis C Overview .

4

Liver Functions Chemical Factory-

>500 chemical

functions

Bile

Immune System

Detoxifies or Filters

Clotting Factors

Hormones

Regenerates Itself!

www.hcvadvocate.org

Page 5: April 2014 - 1 Hepatitis C Overview .

5

Keep the Liver Healthy!

If you have HCV – Avoid Alcohol

Avoid mixing drugs – prescription, over- the-counter, herbs/supplements and street drugs

Eat a healthy, balanced diet based on MyPlate (www.choosemyplate.gov)

www.hcvadvocate.org

Page 6: April 2014 - 1 Hepatitis C Overview .

6

Keep the liver healthy! Get vaccinated!

HAV and HBV vaccines

Avoid toxic substances / fumes

www.hcvadvocate.org

Page 7: April 2014 - 1 Hepatitis C Overview .

7

Hepatitis C Statistics

U.S. Population

More than 3.9 million Americans chronically infected

HCV Populations ~1.5 % to 2% Mexican

Americans ~3 % African Americans

www.hcvadvocate.org

Page 8: April 2014 - 1 Hepatitis C Overview .

8

HCV Antibody tests HCV Elisa II or III

Most common antibody test

OraQuick whole blood and fingerprick approved

A positive antibody test indicates exposure It does not indicate current hepatitis C

infection HCV viral load test performed to indicate active

HCV infection

www.hcvadvocate.org

Page 9: April 2014 - 1 Hepatitis C Overview .

9

Viral Load Tests

Viral Load tests Hepatitis C RNA by PCR – > 5-10 IU/mL HCV RNA by branched DNA Assay – > 615 IU/mL TMA – > 5-10 IU/mL

Why Is a Viral Load Test Important? To confirm active infection Somewhat helps to predict treatment response & used to guide

treatment duration Indication that treatment is working

** Viral load does not correlate with disease progression**

www.hcvadvocate.org

Page 10: April 2014 - 1 Hepatitis C Overview .

10

Genotype Test Genotype (1,2,3,4,5,6 and 7)

U.S. population 70% genotype 1 30% genotypes 2 & 3

Why Is a Genotype Test Important? Guide treatment, what drugs and

treatment duration

www.hcvadvocate.org

Page 11: April 2014 - 1 Hepatitis C Overview .

11

Liver Biopsy

Test for Determining the Health of the Liver Measure inflammation, extent of scarring

(if any), Rule out other diseases Biopsy procedure

Non-invasive markers of liver inflammation – not yet perfected

FibroScan www.hcvadvocate.org

Page 12: April 2014 - 1 Hepatitis C Overview .

12

Transmission- Prevention Direct blood-to-blood transmission

route

Can live on surfaces for up to 6 weeks

Bleach and other disinfectants kill virus, but probably not inside the needle

Not spread casually – need blood

www.hcvadvocate.org

Page 13: April 2014 - 1 Hepatitis C Overview .

13

Transmission

Shared Needles

All Drug Paraphernalia

Blood Before 1992 - transfused, products, procedures

Sexual Transmission(1-3%)

Healthcare Workers – needle sticks

Shared House-hold items – razors & toothbrushes

Mother to Child 4-7%

Tattoos / Piercing

<10% of routes can not be identified

www.hcvadvocate.org

Page 14: April 2014 - 1 Hepatitis C Overview .

14

Prevention Tips Injection and Non-Injection Drugs

Do not share needles, cookers, cottons, straws, pipes, water or any items that might come into contact with blood

Use bleach to clean – if no needle exchange is available

People in Stable Long-Term Monogamous Sexual Relationships CDC – no need to change current sexual

practices – but there is a risk

www.hcvadvocate.org

Page 15: April 2014 - 1 Hepatitis C Overview .

15

Prevention Tips Safer Sex

For so called “high risk groups”

Multiple sexual partners, people with sexually transmitted diseases, infection with HIV or HBV

Any situation where blood is present

www.hcvadvocate.org

Page 16: April 2014 - 1 Hepatitis C Overview .

16

Prevention Tips Mother-to-Child Transmission

Low risk – about 4-7% chance of hepatitis being transmitted to infant

Given the low rate of transmission, pregnancy should not be avoided.

Health-Care Settings Follow standard (universal)

precautions

www.hcvadvocate.org

Page 17: April 2014 - 1 Hepatitis C Overview .

17

Prevention Tips Tattoos & Piercing

Considered a low/no risk in commercial setting that practices safety

Make sure disposable needles and separate ink pots are used and that general safety precautions are followed

Considered a higher risk in other settings

Non-commercial settings such as in prison, parties or on the streets

www.hcvadvocate.org

Page 18: April 2014 - 1 Hepatitis C Overview .

18

Shared Personal Items Household

Cover cuts or sores Do not share personal hygiene items

(toothbrushes, razors, etc.)

Professional Personal Care Settings Standard precautions Disposable equipment Bring own equipment (best advice)

www.hcvadvocate.org

Page 19: April 2014 - 1 Hepatitis C Overview .

19

HCV CAN NOT BE SPREAD BY:

BREASTFEEDING

SNEEZING

HUGGING

COUGHING

FOOD OR WATER

SHARING EATING UTENSILS OR DRINKING GLASSES

CASUAL CONTACT

www.hcvadvocate.org

Page 20: April 2014 - 1 Hepatitis C Overview .

20

Chronic Symptoms Fatigue – mild to

severe

Flu-like symptoms (muscle/joint/fever)

‘Brain Fog’

Liver pain

Loss of appetite

Headaches

Gastro problems

and more……

www.hcvadvocate.org

Page 21: April 2014 - 1 Hepatitis C Overview .

21

Disease Progression 10-25% of HCV positive people

progress on to serious disease usually over 10-40 years Fibrosis

Light scarring Cirrhosis

Compensated vs. decompensated Steatosis

Fatty deposits in the liver

www.hcvadvocate.org

Page 22: April 2014 - 1 Hepatitis C Overview .

22

Treatment Decisions General Treatment

Guidelines

Stable Health

Active HCV Infection

Compensated Liver

Disease

Optimal Response CC genotype Younger Low BMI & Weight Less Steatosis Low Viral Load Minimal Liver

Damage

www.hcvadvocate.org

Page 23: April 2014 - 1 Hepatitis C Overview .

23

Clinical Data - Treatment

Prospective – well designed clinical trial with measurable outcomes Gold Standard

Retrospective – review of data from previous clinical trials Important for looking for trends and

for designing future studies

www.hcvadvocate.org

Page 24: April 2014 - 1 Hepatitis C Overview .

24

Treatment What is interferon?

General antiviral – immune booster – injection

What is ribavirin? Antiviral - used only in combination with

interferon - pill or capsule

What is an HCV inhibitor Direct Acting Antiviral (DAA) – blocks viral

replication

www.hcvadvocate.org

Page 25: April 2014 - 1 Hepatitis C Overview .

25

Approved Medications

Interferon – Pegylated (long-acting interferon)

Ribavirin

HCV Inhibitors Victrelis (boceprevir) – Merck Incivek (telaprevir) – Vertex Olysio (simeprevir) – Janssen Solvadi (sofosbuvir) – Gilead

www.hcvadvocate.org

Page 26: April 2014 - 1 Hepatitis C Overview .

26

Treatment - Genotype 2 & 3

Standard of Care:

Sofosbuvir plus ribavirin

Genotype 2 – 12 weeks = 93% cure rate

Genotype 3 – 24 weeks = 84% cure rate

www.hcvadvocate.org

Page 27: April 2014 - 1 Hepatitis C Overview .

Genotype 1 -

27

• Standard of care:

• Cure rates up to 90%

• Treatment duration 12 to 48 weeks

• Simeprevir, pegylated interferon plus ribavirin

• Sofosbuvir, ribavirin with and without pegylated interferon

www.hcvadvocate.org

Page 28: April 2014 - 1 Hepatitis C Overview .

28

Side-effects Fatigue Anemia Muscle/Joint pain Nausea Headaches Anxiety Depression Dry Skin Rashes Anal itching Photosensitivity

and more.....

Ribavirin can cause birth defects– black box warning:

Women of childbearing age, their partners and female partners of male patients taking ribavirin must practice two forms of effective contraception during to 6 months post-treatment

Note: the majority of side effects are from interferon and ribavirin

www.hcvadvocate.org

Page 29: April 2014 - 1 Hepatitis C Overview .

29

Managing Side-Effects Inject before

bedtime Drink lots of water Low doses of

ibuprofen or acetaminophen

Pain medications

Light exercise Daily moisturizing Vary injection sites Anti-Depressants Plenty of rest Frequent small

meals

Key: support from medical providers, family, friends, work – all areas of life & side effect management

www.hcvadvocate.org

Page 30: April 2014 - 1 Hepatitis C Overview .

Patient Assistance Programs

Partnership for Prescription Assistance www.pparx.org

Needy Meds: www.needymeds.org

HCSP Fact Sheet lists all the pharmaceutical patient assistance programs

Version 12.2www.hcvadvocate.org

Page 31: April 2014 - 1 Hepatitis C Overview .

31

Experimental Therapies Sofosbuvir plus ledipasvir submitted to FDA for

approval (genotype 1) >90% cure rate AbbVie interferon-free therapy phase 3 trials

are completed and AbbVie is expected to apply for FDA approval soon. Approval expected 2014

HCV Advocate’s Drug Pipeline

www.clinicaltrials.gov – search button, type in: HCV

www.hcvadvocate.org

Page 32: April 2014 - 1 Hepatitis C Overview .

32

Complementary Medicine Herbs – milk thistle, licorice root, etc.

Caution: St. Johns Wort should not be taken

with an HCV Protease Inhibitor; Milk Thistle

should not be taken with simeprevir/Olysio

Acupuncture / Acupressure

Traditional Chinese Medicine

www.hcvadvocate.org

Page 33: April 2014 - 1 Hepatitis C Overview .

33

Lifestyle Changes That Help!

Alcohol – Avoid or reduce

Get vaccinated – Hep A & Hep B

Healthy balanced diet

Exercise

Stress Reduction

Support Groups

www.hcvadvocate.org

Page 34: April 2014 - 1 Hepatitis C Overview .

34

Advocate for Yourself! Educate yourself

Establish a good relationship with your doctor

Bring an advocate for doctor’s visits

Ask questions

Keep copies of all medical tests

Keep a diary

Keep an open mind

www.hcvadvocate.org

Page 35: April 2014 - 1 Hepatitis C Overview .

35

Resources –

• HCV Advocate Newsletter

• Education Materials in various languages

• Over 200 fact sheets & guides

• National Support Group Listing

• Recommended links

• Information on hepatitis C, hepatitis B, and HIV/HCV Coinfection

www.hcvadvocate.org